ReviewFrontiers in endocrinology2021

Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6.

Michael A Nauck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.